George M. Lasezkay, CEO at Clearside Biomedical, Inc. (CLSD), sold 18,000 shares at $1.27 ($23K) on 2024-01-19, disclosed to the SEC on 2024-01-19.
Seasonal sale ($23k) by CEO — this insider has traded CLSD in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CLSD | SELL | 2022-01-13 | $13K | — | Filing → |
| CLSD | SELL | 2021-09-23 | $23K | — | Filing → |
| CLSD | SELL | 2021-06-23 | $16K | — | Filing → |